Phase 1 Renal Insufficiency, Chronic Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
Renal Insufficiency, Chronic
Beijing Continent Pharmaceutical Co, Ltd.56 enrolled1 locationNCT07262333
Recruiting
Phase 1
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
Kidney DiseaseRenal ImpairmentRenal Insufficiency, Chronic+3 more
Eli Lilly and Company28 enrolled2 locationsNCT07426380
Recruiting
Phase 1Phase 2
Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial
Kidney Disease, ChronicRenal Insufficiency, ChronicGut Dysbiosis+1 more
Mansoura University72 enrolled1 locationNCT06863194